Brief: ArcticZymes Enters Agreement Regarding COVID-19 Vaccine Candidate
02/07/2020 07:24
July 2 (Reuters) - Arcticzymes Technologies ASA ARCZ.OL :
* ARCTICZYMES HAS ENTERED INTO AN AGREEMENT WITH REITHERA TO
SUPPLY ITS SAN PRODUCT FOR REITHERA'S COVID-19 VACCINE CANDIDATE
* VACCINE CANDIDATE, WHICH IS BASED ON REITHERA'S VIRAL
VECTOR
TECHNOLOGY, IS SCHEDULED TO ENTER CLINICAL TRIALS SOON
* ARCTICZYMES AS, A UNIT OF ARCTICZYMES TECHNOLOGIES ASA,
ANNOUNCES THAT IT HAS ENTERED INTO SUPPLY AGREEMENT WITH
REITHERA SRL (ROME, ITALY) FOR SUPPLY OF SALT ACTIVE NUCLEASE
(SAN-HQ) TO BE USED IN DEVELOPMENT AND MANUFACTURING OF
REITHERA'S NOVEL VACCINE CANDIDATE AGAINST COVID-19
Source text for Eikon: ID:nWkr85l25f
Further company coverage: ARCZ.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))